Xylem Inc.
XYL
$136.30
$3.442.59%
Weiss Ratings | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C- | |||
Reward Grade | B+ | |||
Rating Factors | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Weak | |||
Growth Index | Excellent | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.07 | |||
Price History | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 4.99% | |||
30-Day Total Return | 7.76% | |||
60-Day Total Return | -0.19% | |||
90-Day Total Return | -4.18% | |||
Year to Date Total Return | 20.89% | |||
1-Year Total Return | 45.37% | |||
2-Year Total Return | 44.69% | |||
3-Year Total Return | 7.85% | |||
5-Year Total Return | 85.58% | |||
52-Week High % Change | -9.05% | |||
52-Week Low % Change | 51.68% | |||
Price | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $146.08 | |||
52-Week Low Price | $87.59 | |||
52-Week Low Price (Date) | Oct 30, 2023 | |||
52-Week High Price (Date) | May 21, 2024 | |||
Valuation | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 32.27B | |||
Enterprise Value | 33.57B | |||
Price/Earnings (TTM) | 42.07 | |||
Earnings Per Share (TTM) | 3.16 | |||
Earnings Per Share Growth | 68.57% | |||
Price/Earnings To Growth | 0.61 | |||
Price/Sales (TTM) | 3.85 | |||
Price/Book (Q) | 3.12 | |||
Enterprise Value/Revenue (TTM) | 4.00 | |||
Price | $136.30 | |||
Enterprise Value/EBITDA (TTM) | 21.42 | |||
Enterprise Value/EBIT | 33.43 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 243.54M | |||
Dividend Yield | 1.06% | |||
Div. Per Share (Most Recent) | $0.36 | |||
Dividend Per Share (TTM) | $1.41 | |||
Payout Ratio (TTM) | 43.79% | |||
Dividend Per Share (Most Recent) | $0.36 | |||
Company Info | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 202 869 9150 | |||
Address | 300 Water Street SE Washington, DC 20003 | |||
Website | www.xylem.com | |||
Country | United States | |||
Year Founded | 2011 | |||
Profitability | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 11.95% | |||
Profit Margin | 9.11% | |||
Management Effectiveness | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 3.94% | |||
Return on Equity | 7.55% | |||
Income Statement | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 8.40B | |||
Total Revenue (TTM) | 8.40B | |||
Revenue Per Share | $34.48 | |||
Gross Profit (TTM) | 3.09B | |||
EBITDA (TTM) | 1.57B | |||
EBIT (TTM) | 1.00B | |||
Net Income (TTM) | 765.00M | |||
Net Income Avl. to Common (TTM) | 765.00M | |||
Total Revenue Growth (Q YOY) | 25.96% | |||
Earnings Growth (Q YOY) | 110.87% | |||
EPS Diluted (TTM) | 3.16 | |||
EPS Diluted Growth (Q YOY) | 78.69% | |||
Balance Sheet | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 815.00M | |||
Cash Per Share (Q) | $3.35 | |||
Total Current Assets (Q) | 3.78B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 10.35B | |||
Current Ratio (Q) | 1.852 | |||
Book Value Per Share (Q) | $42.57 | |||
Total Assets (Q) | 15.77B | |||
Total Current Liabilities (Q) | 2.04B | |||
Total Debt (Q) | 2.10B | |||
Total Liabilities (Q) | 5.42B | |||
Total Common Equity (Q) | 10.34B | |||
Cash Flow | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -267.00M | |||
Cash from Financing (TTM) | -811.00M | |||
Net Change in Cash (TTM) | 107.00M | |||
Levered Free Cash Flow (TTM) | 941.38M | |||
Cash from Operations (TTM) | 1.21B | |||